Ando Yuichi

2019 - 2022 Factors involved in the efficacy and safety of biopharmaceuticals

2017 - 2020 Mechanism of diarrhea/enteritis caused by anticancer drugs and development of new treatment

2016 - 2020 Screening and prevention of vascular events for cancer patients, and investigation of the mechanisms.

2016 - 2019 Study of the infusion reaction by rituximab

2015 - 2019 Elucidation of sarcopenia mechanism in the cancer cachexia

2014 - 2018 Establishment of bone metastasis treatment by regulating hyaluronan network and osteoclast

2014 - 2018 Clinical significance of sarcopenia in cancer chemotherapy

2014 - 2017 Genetic analysis of peritoneal dissemination of gastrointestinal cancer

2014 - 2017 Mechanisms of delayed elimination and decreased plasma protein binding of anticancer drugs which are mainly eliminated via the liver in cancer patients with severe renal failure

2013 - 2016 Investigation of the infusion reaction development coursed by molecular target medicine prescription

2011 - 2013 Ophthalmologic assessment of retinal vessels as a biomarker of the pharmacological response to antiangiogenic cancer chemotherapy

2010 - 2012 Genetic backgrounds of peripheral neuropathy induced by chemotherapy

2009 - 2011 Development of personalized medicine for cancer chemotherapy according to a variety of sensitivity and pharmacokinetics

2008 - 2010 Clinical and genetic factors of drug-induced QT interval prolongation in patients who receive cancer chemotherapy

2008 - 2010 Identification of Epithelial-to-Mesenchymal Transition-Associated Genes as Therapeutic Targets for Lung Cancer

2004 - 2006 Development of clinical genome information systems for pharmacokinetics analysis

2003 - 2004 抗癌剤化学療法の個別化における薬物代謝酵素遺伝子多型診断の臨床応用

-

-